Neoadjuvant Palbociclib + Anastrozole in ER+/HER2- Breast Cancer

Slideset - This single-arm phase II study demonstrated enhanced cell cycle arrest with the addition of palbociclib to neoadjuvant anastrozole in patients with ER+/HER2- early breast cancer.
Source: Clinical Care Options Breast Cancer - Category: Cancer & Oncology Source Type: research